Year |
Citation |
Score |
2019 |
Geissner A, Reinhardt A, Rademacher C, Johannssen T, Monteiro J, Lepenies B, Thépaut M, Fieschi F, Mrázková J, Wimmerova M, Schuhmacher F, Götze S, Grünstein D, Guo X, Hahm HS, ... Kandasamy J, et al. Microbe-focused glycan array screening platform. Proceedings of the National Academy of Sciences of the United States of America. PMID 30670663 DOI: 10.1073/Pnas.1800853116 |
0.558 |
|
2019 |
Tiwari V, Singh AK, Chaudhary P, Seeberger PH, Kandasamy J. Synthesis of photolabile protecting group (PPG) protected uronic acid building blocks: applications in carbohydrate synthesis with the assistance of a continuous flow photoreactor Organic Chemistry Frontiers. 6: 3859-3863. DOI: 10.1039/C9Qo01010F |
0.411 |
|
2014 |
Nonaka M, Bao X, Matsumura F, Götze S, Kandasamy J, Kononov A, Broide DH, Nakayama J, Seeberger PH, Fukuda M. Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sites Proceedings of the National Academy of Sciences of the United States of America. 111: 8173-8178. PMID 24835176 DOI: 10.1073/Pnas.1319870111 |
0.383 |
|
2014 |
Hurevich M, Kandasamy J, Ponnappa BM, Collot M, Kopetzki D, McQuade DT, Seeberger PH. Continuous photochemical cleavage of linkers for solid-phase synthesis. Organic Letters. 16: 1794-7. PMID 24611474 DOI: 10.1021/Ol500530Q |
0.417 |
|
2014 |
Gunn G, Dai Y, Du M, Belakhov V, Kandasamy J, Schoeb TR, Baasov T, Bedwell DM, Keeling KM. Long-term nonsense suppression therapy moderates MPS I-H disease progression. Molecular Genetics and Metabolism. 111: 374-81. PMID 24411223 DOI: 10.1016/J.Ymgme.2013.12.007 |
0.56 |
|
2014 |
Kandasamy J, Schuhmacher F, Hahm HS, Klein JC, Seeberger PH. Modular automated solid phase synthesis of dermatan sulfate oligosaccharides. Chemical Communications (Cambridge, England). 50: 1875-7. PMID 24402061 DOI: 10.1039/C3Cc48860H |
0.633 |
|
2014 |
Gunn GG, Dai Y, Du M, Beklakhov V, Kandasamy J, Schoeb TR, Baasov T, Bedwell DM, Keeling KM. Long-term nonsense suppression therapy with NB84 moderates MPS IH disease progression Molecular Genetics and Metabolism. 111: S50. DOI: 10.1016/J.Ymgme.2013.12.106 |
0.491 |
|
2013 |
Keeling KM, Wang D, Dai Y, Murugesan S, Chenna B, Clark J, Belakhov V, Kandasamy J, Velu SE, Baasov T, Bedwell DM. Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression. Plos One. 8: e60478. PMID 23593225 DOI: 10.1371/Journal.Pone.0060478 |
0.557 |
|
2013 |
Kandasamy J, Hurevich M, Seeberger PH. Automated solid phase synthesis of oligoarabinofuranosides Chemical Communications. 49: 4453-4455. PMID 23370381 DOI: 10.1039/C3Cc00042G |
0.452 |
|
2013 |
Shalev M, Kandasamy J, Skalka N, Belakhov V, Rosin-Arbesfeld R, Baasov T. Development of generic immunoassay for the detection of a series of aminoglycosides with 6'-OH group for the treatment of genetic diseases in biological samples. Journal of Pharmaceutical and Biomedical Analysis. 75: 33-40. PMID 23312382 DOI: 10.1016/j.jpba.2012.11.014 |
0.546 |
|
2012 |
Kandasamy J, Atia-Glikin D, Shulman E, Shapira K, Shavit M, Belakhov V, Baasov T. Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: A strategy for treatment of genetic diseases caused by nonsense mutations Journal of Medicinal Chemistry. 55: 10630-10643. PMID 23148581 DOI: 10.1021/jm3012992 |
0.531 |
|
2012 |
Wang D, Belakhov V, Kandasamy J, Baasov T, Li SC, Li YT, Bedwell DM, Keeling KM. The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse. Molecular Genetics and Metabolism. 105: 116-25. PMID 22056610 DOI: 10.1016/J.Ymgme.2011.10.005 |
0.566 |
|
2011 |
Kandasamy J, Atia-Glikin D, Belakhov V, Baasov T. Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations Medchemcomm. 2: 165. DOI: 10.1039/C0MD00195C |
0.515 |
|
2010 |
Pokrovskaya V, Nudelman I, Kandasamy J, Baasov T. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases. Methods in Enzymology. 478: 437-62. PMID 20816493 DOI: 10.1016/S0076-6879(10)78021-6 |
0.565 |
|
Show low-probability matches. |